88 related articles for article (PubMed ID: 20079762)
41. The Kv1.3 channel blocker Vm24 enhances muscle glucose transporter 4 mobilization but does not reduce body-weight gain in diet-induced obese male rats.
Jaimes-Hoy L; Gurrola GB; Cisneros M; Joseph-Bravo P; Possani LD; Charli JL
Life Sci; 2017 Jul; 181():23-30. PubMed ID: 28549558
[TBL] [Abstract][Full Text] [Related]
42. Decrease of a Current Mediated by Kv1.3 Channels Causes Striatal Cholinergic Interneuron Hyperexcitability in Experimental Parkinsonism.
Tubert C; Taravini IRE; Flores-Barrera E; Sánchez GM; Prost MA; Avale ME; Tseng KY; Rela L; Murer MG
Cell Rep; 2016 Sep; 16(10):2749-2762. PubMed ID: 27568555
[TBL] [Abstract][Full Text] [Related]
43. Brownian dynamics simulations of the recognition of the scorpion toxin maurotoxin with the voltage-gated potassium ion channels.
Fu W; Cui M; Briggs JM; Huang X; Xiong B; Zhang Y; Luo X; Shen J; Ji R; Jiang H; Chen K
Biophys J; 2002 Nov; 83(5):2370-85. PubMed ID: 12414674
[TBL] [Abstract][Full Text] [Related]
44. The 'functional' dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channels.
Mouhat S; Mosbah A; Visan V; Wulff H; Delepierre M; Darbon H; Grissmer S; De Waard M; Sabatier JM
Biochem J; 2004 Jan; 377(Pt 1):25-36. PubMed ID: 12962541
[TBL] [Abstract][Full Text] [Related]
45. OdK2, a Kv1.3 channel-selective toxin from the venom of the Iranian scorpion Odonthobuthus doriae.
Abdel-Mottaleb Y; Vandendriessche T; Clynen E; Landuyt B; Jalali A; Vatanpour H; Schoofs L; Tytgat J
Toxicon; 2008 Jun; 51(8):1424-30. PubMed ID: 18471844
[TBL] [Abstract][Full Text] [Related]
46. Molecular dynamics of Kv1.3 ion channel and structural basis of its inhibition by scorpion toxin-OSK1 derivatives.
Bhuyan R; Seal A
Biophys Chem; 2015; 203-204():1-11. PubMed ID: 26001067
[TBL] [Abstract][Full Text] [Related]
47. Murine K2P5.1 Deficiency Has No Impact on Autoimmune Neuroinflammation due to Compensatory K2P3.1- and KV1.3-Dependent Mechanisms.
Bittner S; Bobak N; Hofmann MS; Schuhmann MK; Ruck T; Göbel K; Brück W; Wiendl H; Meuth SG
Int J Mol Sci; 2015 Jul; 16(8):16880-96. PubMed ID: 26213925
[TBL] [Abstract][Full Text] [Related]
48. Selective blockage of Kv1.3 and Kv3.1 channels increases neural progenitor cell proliferation.
Liebau S; Pröpper C; Böckers T; Lehmann-Horn F; Storch A; Grissmer S; Wittekindt OH
J Neurochem; 2006 Oct; 99(2):426-37. PubMed ID: 17029597
[TBL] [Abstract][Full Text] [Related]
49. Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterisation.
Fraser SP; Grimes JA; Diss JK; Stewart D; Dolly JO; Djamgoz MB
Pflugers Arch; 2003 Aug; 446(5):559-71. PubMed ID: 12838421
[TBL] [Abstract][Full Text] [Related]
50. Isolation, chemical and functional characterization of several new K(+)-channel blocking peptides from the venom of the scorpion Centruroides tecomanus.
Olamendi-Portugal T; Bartok A; Zamudio-Zuñiga F; Balajthy A; Becerril B; Panyi G; Possani LD
Toxicon; 2016 Jun; 115():1-12. PubMed ID: 26921461
[TBL] [Abstract][Full Text] [Related]
51. Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha-subunits.
Mourre C; Chernova MN; Martin-Eauclaire MF; Bessone R; Jacquet G; Gola M; Alper SL; Crest M
J Pharmacol Exp Ther; 1999 Dec; 291(3):943-52. PubMed ID: 10565809
[TBL] [Abstract][Full Text] [Related]
52. Expression and biophysical properties of Kv1 channels in supragranular neocortical pyramidal neurones.
Guan D; Lee JC; Tkatch T; Surmeier DJ; Armstrong WE; Foehring RC
J Physiol; 2006 Mar; 571(Pt 2):371-89. PubMed ID: 16373387
[TBL] [Abstract][Full Text] [Related]
53. Identification of novel Kv1.3 blockers using a fluorescent cell-based ion channel assay.
Slack M; Kirchhoff C; Moller C; Winkler D; Netzer R
J Biomol Screen; 2006 Feb; 11(1):57-64. PubMed ID: 16314404
[TBL] [Abstract][Full Text] [Related]
54. The small neurotoxin apamin blocks not only small conductance Ca
Voos P; Yazar M; Lautenschläger R; Rauh O; Moroni A; Thiel G
Eur Biophys J; 2017 Sep; 46(6):517-523. PubMed ID: 28108814
[TBL] [Abstract][Full Text] [Related]
55. Kv1.3: a multifunctional channel with many pathological implications.
Serrano-Albarrás A; Estadella I; Cirera-Rocosa S; Navarro-Pérez M; Felipe A
Expert Opin Ther Targets; 2018 Feb; 22(2):101-105. PubMed ID: 29258373
[No Abstract] [Full Text] [Related]
56. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease.
Valverde P; Kawai T; Taubman MA
J Bone Miner Res; 2004 Jan; 19(1):155-64. PubMed ID: 14753747
[TBL] [Abstract][Full Text] [Related]
57. Minocycline decreases in vitro microglial motility, beta1-integrin, and Kv1.3 channel expression.
Nutile-McMenemy N; Elfenbein A; Deleo JA
J Neurochem; 2007 Dec; 103(5):2035-46. PubMed ID: 17868321
[TBL] [Abstract][Full Text] [Related]
58. Modulation of voltage-dependent and inward rectifier potassium channels by 15-epi-lipoxin-A4 in activated murine macrophages: implications in innate immunity.
Moreno C; Prieto P; Macías Á; Pimentel-Santillana M; de la Cruz A; Través PG; Boscá L; Valenzuela C
J Immunol; 2013 Dec; 191(12):6136-46. PubMed ID: 24249731
[TBL] [Abstract][Full Text] [Related]
59. T Cell Subset and Stimulation Strength-Dependent Modulation of T Cell Activation by Kv1.3 Blockers.
Fung-Leung WP; Edwards W; Liu Y; Ngo K; Angsana J; Castro G; Wu N; Liu X; Swanson RV; Wickenden AD
PLoS One; 2017; 12(1):e0170102. PubMed ID: 28107393
[TBL] [Abstract][Full Text] [Related]
60. N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.
Chang SC; Huq R; Chhabra S; Beeton C; Pennington MW; Smith BJ; Norton RS
FEBS J; 2015 Jun; 282(12):2247-59. PubMed ID: 25864722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
